|
|
| MRD / Regn No. |
: 20260000060 |
Date |
: 17/07/2026 |
| Patient Name |
: Deepa Ragavan |
Age & Gender |
: 44 Yrs. / Female |
| Contact No. |
: 9597706584 |
UHID |
: |
| Ht / Wt / BMI |
: 155.5 / 73.9 / 30.56 |
BP S / BP D |
: 130 / 92 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
OBESITY (02/Feb/2021) | PREDIABETES (02/Feb/2026) | |
|
Subjective |
: |
INCIDENTAL DYSGLYCEMIA,HAS STOPPED SEMAGLUTIDE
|
|
Objective |
: |
NONE |
|
Analysis |
: |
OBESITY,PREDIABETES,VITAMIN D DEFICIENCY,OBESITY WITH MECHANICAL AND METABOLIC COMPLICATIONS,FIBROCYSTIC BREAST DISEASAE,VCDR > 0.3 |
|
Plan |
: |
INCREASE SEMAGLUTIDE TO 0.5 MG,SEE ME IN 1 MONTH |
|
| Salient Investigations |
: |
BUN BLOOD UREA NITROGEN: 8.7 mg/dL | HEMOGLOBIN: 10.7 g/dL | MCV - MEAN CORPUSCULAR VOLUME: 75 fL | PLATELETS: 245 thou cells/ ul | WBC WHITE BLOOD CELLS: 610 K/uL | FASTING PLASMA GLUCOSE (FPG): 102 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 82 mg/dL | HDL HIGH DENSITY LIPOPROTEIN: 34 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 108 mg/dL | TGL TRIGLYCERIDE: 85 mg/dL | TOTAL CHOLESTEROL: 160 mg/dl | ALBUMIN (SERUM): 4.1 g/dL | ALKALINE PHOSPHOTASE: 93 IU/L | DIRECT BILIRUBIN: 0.1 mg/dl | SGOT (AST): 12.5 U/L | SGPT (ALT): 9.8 IU/L | TOTAL BILIRUBIN: 0.2 mg/dL | CHLORIDE: 102 meq/L | POTASSIUM: 4.4 meQ/L | SODIUM: 138 meq/L | HDL HIGH DENSITY LIPOPROTEIN: 34 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 108 mg/dL | TGL TRIGLYCERIDE: 85 mg/dL | TOTAL CHOLESTEROL: 160 mg/dl | ALBUMIN (SERUM): 4.1 g/dL | ALKALINE PHOSPHOTASE: 93 IU/L | DIRECT BILIRUBIN: 0.1 mg/dl | SGOT (AST): 12.5 U/L | SGPT (ALT): 9.8 IU/L | FIB4: 0.72 | TOTAL BILIRUBIN: 0.2 mg/dL | CHLORIDE: 102 meq/L | POTASSIUM: 4.4 meQ/L | SODIUM: 138 meq/L |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
OIL OF PRIMROSE 1000 MG
PRIMOSA |
|
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
|
|
2 |
CAPSULE CHOLECALCIFEROL 2000 IU
D RISE
Medicine For VITAMIN D |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
|
|
3 |
INJECTION SEMAGLUTIDE 0.5 MG
SEMALIX 0.5
Medicine For DIABETES OBESITY HEART KIDNEY PROTECTION |
SQ |
EVERY WEEK |
AS DIRECTED NO RELATION TO FOOD
|
TILL NEXT VISIT |
| MAY CAUSE NAUSEA CONSTIPATION OR VISUAL DISTURBANCE | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: RARE VERY RARE INSTANCES OF EYE DISTURBANCE WITH SEMAGLUTIDE HAVE BEEN REPORTED IF YOU HAVE AN EYE DISTURBANCE PLS INFORM US |
| Next Visit |
: 17/Aug/2026 |
| Tests Suggested For Next Visit |
: NONE |
| |
|
| |
|
Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu /
48748 HPRID: 71-0638-2075-7542
This is a Computer generated Prescription |
Powered By:  |